Plain-English translation of NCT05164107 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the Globe Mapping and Pulsed Field Ablation System, which uses pulsed energy to help correct atrial fibrillation — a condition where your heart beats irregularly. The device is designed to map your heart's electrical activity and then carefully deliver energy to help restore a normal rhythm. Researchers want to make sure this treatment is safe and works well for patients like you.
Current treatments for atrial fibrillation work, but doctors are always looking for safer and more effective options. This trial exists to see if this new pulsed energy approach offers patients a better alternative with fewer complications.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo the ablation procedure using the new pulsed energy device in a hospital setting. The procedure itself is similar to standard heart rhythm treatments — you'll be sedated, and doctors will guide a catheter through your blood vessels to your heart. Researchers will monitor your safety and how well the treatment works for your specific condition.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Czechia